Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, 7 Divinity Ave, Cambridge, MA 02138, USA.
Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, Boston, MA 02115, USA.
Cardiovasc Res. 2022 Mar 25;118(5):1173-1187. doi: 10.1093/cvr/cvab161.
Cellular senescence is a state of irreversible cell cycle arrest associated with ageing. Senescence of different cardiac cell types can direct the pathophysiology of cardiovascular diseases (CVDs) such as atherosclerosis, myocardial infarction, and cardiac fibrosis. While age-related telomere shortening represents a major cause of replicative senescence, the senescent state can also be induced by oxidative stress, metabolic dysfunction, and epigenetic regulation, among other stressors. It is critical that we understand the molecular pathways that lead to cellular senescence and the consequences of cellular senescence in order to develop new therapeutic approaches to treat CVD. In this review, we discuss molecular mechanisms of cellular senescence, explore how cellular senescence of different cardiac cell types (including cardiomyocytes, cardiac endothelial cells, cardiac fibroblasts, vascular smooth muscle cells, and valve interstitial cells) can lead to CVD, and highlight potential therapeutic approaches that target molecular mechanisms of cellular senescence to prevent or treat CVD.
细胞衰老是一种与衰老相关的不可逆细胞周期停滞状态。不同心脏细胞类型的衰老可导致心血管疾病(CVDs)的病理生理学改变,如动脉粥样硬化、心肌梗死和心肌纤维化。虽然与年龄相关的端粒缩短是复制性衰老的主要原因,但衰老状态也可由氧化应激、代谢功能障碍和表观遗传调控等应激因素引起。为了开发治疗 CVD 的新疗法,了解导致细胞衰老的分子途径以及细胞衰老的后果至关重要。在这篇综述中,我们讨论了细胞衰老的分子机制,探讨了不同心脏细胞类型(包括心肌细胞、心脏内皮细胞、心脏成纤维细胞、血管平滑肌细胞和瓣膜间质细胞)的细胞衰老如何导致 CVD,并强调了靶向细胞衰老分子机制以预防或治疗 CVD 的潜在治疗方法。